Blood Phoenixin-14 Levels and Echocardiographic Findings in Infants of Diabetic Mothers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-5
SponsorKonya City Hospital
About this trial
In this study, the investigators hypothesize that echocardiographic pathologies observed in infants of diabetic mothers are associated with elevated serum phoenixin-14 levels.
Eligibility criteria
Qualifiers
Infants of diabetic mothers
Healthy term infants
Disqualifiers
Infants whose families did not provide consent
Infants with a syndromic appearance or congenital heart disease
Trial design
Treatments tested in this trial
- echocardiographic evaluation and blood phoenixin-14 level
Treatment groups
84 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov